Aclaris (ACRS) Gains Momentum With Strategic Business Expansion
Aclaris Therapeutics, Inc. (NASDAQ: ACRS) share are rising 30.74% on the US stock charts, to $2.67 as of the latest market check. This spike in ACRS stock marks a turning point in the company’s strategic growth and comes after the announcement of significant equity and business expansion activities. Immunology Portfolio Supported by Licensing Agreement Through […]
Aclaris (ACRS) Gains Momentum With Strategic Business Expansion Read More »